Ningbo Menovo Pharmaceutical Co (SHSE:603538) 3-Year EBITDA Growth Rate : -24.10% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co 3-Year EBITDA Growth Rate?

Ningbo Menovo Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.14.

During the past 12 months, Ningbo Menovo Pharmaceutical Co's average EBITDA Per Share Growth Rate was -94.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -24.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ningbo Menovo Pharmaceutical Co was 42.10% per year. The lowest was -24.10% per year. And the median was 18.10% per year.

Competitive Comparison of Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Ningbo Menovo Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ningbo Menovo Pharmaceutical Co (SHSE:603538) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ningbo Menovo Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040

Website

http://www.menovopharm.com

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Executives

Xu Jian	senior management
Cao Qian	Director
Yao Fang	Director
Ying Gao Feng	Director
Sun Yan	Director
Shi Jian Xiang	Director
Wu Feng Yun	Director
Tu Ying	Director
Yao Cheng Zhi	Director
Zheng Hui Lin	Supervisors
Jiao Hua	senior management

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Headlines

No Headlines